DENDRITIC CELLS AND THEIR ROLE IN CANCER IMMUNOTHERAPY
Journal: Cardiometry
Year: 2023

Cytotoxic CD8+ T lymphocytes (CD8+ CTLs) are key effector cells, which recognize and kill tumor cells, and are therefore preferred targets for improved cancer immunotherapy. Aim: To investigate the role of dendritic cells (DCs) in the initiation of antigen-specific immunity in cancer immunotherapy.